Cresanto Global Limited (formerly Raymed Labs Limited) reported a significant reduction in its quarterly loss for Q1FY26, posting a net loss of ₹5.88 lakh compared to ₹23.54 lakh in the preceding quarter ended March 31, 2026. The company recorded nil revenue from operations during the period.

The Board of Directors approved the unaudited financial results on August 13, 2026. The results were reviewed by K T P S & Co., Chartered Accountants, in accordance with Regulation 33 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Financial Performance

The company’s total income remained at nil for the quarter, continuing the trend from Q4FY25 where only minimal other income was recorded. Total expenses declined substantially, driving the improvement in the bottom line.

Employee benefits expenses stood at ₹0.46 lakh, down from ₹3.40 lakh in the previous quarter. Other expenses were ₹5.42 lakh, compared to ₹4.44 lakh in Q4FY25. Finance costs, which were ₹15.86 lakh in the prior quarter, were nil in Q1FY26.

What the Numbers Show

The sharp contraction in the net loss is primarily attributable to the elimination of finance costs and a reduction in employee benefits, rather than any operational revenue generation. With revenue from operations remaining at nil, the company continues to operate without core business income, relying on cost containment to reduce quarterly losses.

Cresanto Global Limited has scheduled its 34th Annual General Meeting (AGM) for Monday, August 31, 2026, at 12:00 p.m. (IST) via Video Conferencing/Other Audio Visual Means. The primary objective is to secure shareholder approval for shifting the company’s registered office from Uttar Pradesh to Maharashtra, a move management states will facilitate effective oversight given that directors and key managerial personnel reside in Mumbai. This structural change is critical for operational efficiency and requires a special resolution under Section 13(4) of the Companies Act, 2013.

The Board of Directors approved the proposal on July 23, 2026, citing avoidance of inconvenience. Shareholders must also approve the alteration of Clause II of the Memorandum of Association to reflect the new location in the State of Maharashtra, ROC Mumbai I. Additionally, the meeting will address material related-party transactions (RPTs) and director re-appointments as per regulatory mandates.

Key Dates and E-Voting Timeline

In compliance with Regulation 30, 34, and 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has provided specific timelines for the AGM and remote e-voting. The facility is offered through National Securities Depository Limited (NSDL).

Shareholders are also being asked to ratify existing and future material related-party transactions through an ordinary resolution, as mandated by Regulation 23 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The proposed cap covers transactions with entities having common management or significant influence, extending until the 35th AGM in calendar year 2027.

Related-Party Transaction Caps

The transactions involve loans, services, and corporate guarantees. Interest rates for borrowings from individuals typically range from 8% to 12%, with repayments on demand and a tenure of one year. These facilities are unsecured and intended to meet working capital requirements.

What the Numbers Show

The scale of the proposed related-party transactions is substantial relative to the company’s current operational footprint. With a standalone turnover of just ₹5.39 lakhs in FY26, the proposed RPT limit of ₹45 crore represents a significant potential exposure. Notably, the company reported a Profit After Tax loss of ₹43.03 lakhs in FY26. While the filings state these transactions are at arm’s length and in the ordinary course of business, the high dependency on related-party funding suggests that internal capital generation remains insufficient to support business expansion needs without external promoter support.

In ordinary business, the meeting will see the re-appointment of Hitesh Bajoria as a Non-Executive Director, who retires by rotation. Bajoria, who holds 285,592 equity shares, has attended six board meetings during FY26. The notice was signed by Prashant Nathmal Bajaj, Managing Director, on August 6, 2026, in Mumbai.